260 related articles for article (PubMed ID: 36893885)
21. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.
Zhang D; Man D; Lu J; Jiang Y; Ding B; Su R; Tong R; Chen J; Yang B; Zheng S; Chen D; Wu J
Adv Sci (Weinh); 2023 May; 10(15):e2206669. PubMed ID: 36994647
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
23. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
24. Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells.
Jo A; Bae JH; Yoon YJ; Chung TH; Lee EW; Kim YH; Joh HM; Chung JW
Cell Death Dis; 2022 Mar; 13(3):212. PubMed ID: 35256587
[TBL] [Abstract][Full Text] [Related]
25. FSP1: a key regulator of ferroptosis.
Li W; Liang L; Liu S; Yi H; Zhou Y
Trends Mol Med; 2023 Sep; 29(9):753-764. PubMed ID: 37357101
[TBL] [Abstract][Full Text] [Related]
26. PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti-PD-1 Immunotherapy.
Zheng Y; Wang Y; Lu Z; Wan J; Jiang L; Song D; Wei C; Gao C; Shi G; Zhou J; Fan J; Ke A; Zhou L; Cai J
Adv Sci (Weinh); 2023 Oct; 10(29):e2301928. PubMed ID: 37705495
[TBL] [Abstract][Full Text] [Related]
27. Differences in hepatocellular iron metabolism underlie sexual dimorphism in hepatocyte ferroptosis.
Tao H; Dar HY; Tian C; Banerjee S; Glazer ES; Srinivasan S; Zhu L; Pacifici R; He P
Redox Biol; 2023 Nov; 67():102892. PubMed ID: 37741044
[TBL] [Abstract][Full Text] [Related]
28. Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance.
Lee J; Roh JL
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371948
[TBL] [Abstract][Full Text] [Related]
29. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
30. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
31. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
32. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
Apoptosis; 2024 Apr; ():. PubMed ID: 38615304
[TBL] [Abstract][Full Text] [Related]
33. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
[TBL] [Abstract][Full Text] [Related]
34. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
35. TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.
Gong J; Liu Y; Wang W; He R; Xia Q; Chen L; Zhao C; Gao Y; Shi Y; Bai Y; Liao Y; Zhang Q; Zhu F; Wang M; Li X; Qin R
Adv Sci (Weinh); 2023 Oct; 10(29):e2302318. PubMed ID: 37587773
[TBL] [Abstract][Full Text] [Related]
36. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma.
Meng J; Yang X; Huang J; Tuo Z; Hu Y; Liao Z; Tian Y; Deng S; Deng Y; Zhou Z; Lovell JF; Jin H; Liu Y; Yang K
Adv Sci (Weinh); 2023 Jul; 10(20):e2300517. PubMed ID: 37132587
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review).
Liu RJ; Yu XD; Yan SS; Guo ZW; Zao XB; Zhang YS
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757345
[TBL] [Abstract][Full Text] [Related]
39. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy.
Yang N; Pan X; Zhou X; Liu Z; Yang J; Zhang J; Jia Z; Shen Q
Adv Healthc Mater; 2024 Mar; 13(7):e2302752. PubMed ID: 37975280
[TBL] [Abstract][Full Text] [Related]
40. RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
Xie W; Wang J; Tian S; Zhao H; Cao L; Liang Z; Yang J; Zhao Y; Wang B; Jiang F; Ma J
Oncogene; 2024 May; 43(19):1463-1475. PubMed ID: 38514855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]